The company has a multi-year lead on battery technology for defense applications, and its balance sheet is well-positioned to drive sustainable growth, the brokerage stated.

Clients transitioning to production orders from sampling cells could be a drag on near-term revenue growth, but provides a pathway to higher margins and operating leverage, according to the note.

The company's efforts to transition clients to SiCore from the SiMaxx product line could be complete by H2 2026 and support expectations that the company reaches profitability in Q4, analysts wrote.

The brokerage said it now expects a fiscal 2025 loss of $0.20 per share on revenue of $72.8 million from a loss of $0.19 and revenue of $82.8 million earlier. It guided for 2027 EPS of $0.07 on revenue of $215 million. For 2028, it expects EPS of $0.61 on revenue of $433 million.

The brokerage said it reiterated its outperform rating on the stock and price target of $17 per share.

Price: 8.65, Change: -0.42, Percent Change: -4.63

http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.